Novartis' Hemophilia Drug Patent Suit Stays In Texas
A federal judge in the Eastern District of Texas won't reconsider Wyeth Inc.'s bid to move Novartis AG's lawsuit accusing it of infringing patents for hemophilia treatments....To view the full article, register now.
Already a subscriber? Click here to view full article